Prelude Therapeutics Inc Working Capital to Net Assets Ratio
Prelude Therapeutics Inc working capital to net assets ratio. Prelude Therapeutics Inc (PRLD) has a Working Capital to Net Assets ratio of 68.6% as of September 2025. Working capital of $40.14 Million (current assets of $58.33 Million minus current liabilities of $18.19 Million) is measured against net assets of $58.53 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Prelude Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Prelude Therapeutics Inc (2018–2024)
Working capital to net assets ratio of Prelude Therapeutics Inc from 2018 to 2024. This chart shows how Prelude Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2018 to 2024. As of September 2025, the ratio stands at 68.6%, reflecting working capital of $40.14 Million against net assets of $58.53 Million USD. See defensive interval ratio of Prelude Therapeutics Inc to measure how many days the company can operate on defensive assets alone.
Prelude Therapeutics Inc Working Capital to Net Assets Ratio by Year (2018–2024)
Prelude Therapeutics Inc working capital to net assets ratio by year from 2018 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Prelude Therapeutics Inc from 2018 to 2024, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see PRLD total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 83.9% | $110.25 Million | $131.46 Million | $135.90 Million | $25.64 Million | ▼ -6.3 pp |
| 2023 | 90.2% | $213.76 Million | $237.09 Million | $235.59 Million | $21.83 Million | ▼ -3.3 pp |
| 2022 | 93.5% | $182.68 Million | $195.44 Million | $204.38 Million | $21.70 Million | ▼ -3.0 pp |
| 2021 | 96.5% | $275.91 Million | $285.90 Million | $295.12 Million | $19.20 Million | ▼ -2.2 pp |
| 2020 | 98.7% | $209.43 Million | $212.18 Million | $220.81 Million | $11.38 Million | ▲ +129.8 pp |
| 2019 | -31.1% | $15.39 Million | $-49.41 Million | $20.22 Million | $4.83 Million | ▲ +26.8 pp |
| 2018 | -57.9% | $13.15 Million | $-22.69 Million | $15.60 Million | $2.45 Million | — |